Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in ELIEM THERAPEUTICS INC
RA CAPITAL MANAGEMENT, L.P. holds 11.3M shares of CLYM (ELIEM THERAPEUTICS INC), worth $77.7M as of 2025-Q4. The position was decreased (-64.0% shares). CLYM represents 0.8% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.
Current Value
$77.7M
Current Shares
11.3M
Total Value Change
-$145.7M
Total Shares Change
-20.1M
Other major holders of CLYM: JANUS HENDERSON GROUP PLC, VANGUARD GROUP INC, Woodline Partners LP
Decreased |
| 11.3M |
-64.0% |
| $77.7M |
| 0.8% |
| $4.03 |
0 |
| 2025-Q3 | Unchanged | 31.4M | 0.0% | $63.2M | 0.8% | $1.99 | 0 |
| 2025-Q2 | Unchanged | 31.4M | 0.0% | $39M | 0.7% | $1.18 | 0 |
| 2025-Q1 | Unchanged | 31.4M | 0.0% | $38.3M | 0.6% | $1.28 | 0 |
| 2024-Q4 | Unchanged | 31.4M | 0.0% | $56.6M | 0.8% | $1.85 | 0 |
| 2024-Q3 | Unchanged | 31.4M | 0.0% | $159.9M | 1.8% | $4.98 | 0 |
| 2024-Q2 | Increased | 31.4M | +138.9% | $223.4M | 3.0% | $7.11 | 85 |